Cargando…
Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial
BACKGROUND: Chronic oxaliplatin-induced peripheral neurotoxicity (OIPN) is the most troublesome and dose-limiting side effect of oxaliplatin. There is no effective treatment for chronic OIPN. We conducted a randomised controlled trial to investigate the efficacy of monosialotetrahexosylganglioside (...
Autores principales: | Zhou, Likun, Liu, Rui, Huang, Dingzhi, Li, Hongli, Ning, Tao, Zhang, Le, Ge, Shaohua, Bai, Ming, Wang, Xia, Yang, Yuchong, Wang, XinYi, Chen, Xingyun, Gao, Zhiying, Luo, Laizhi, Yang, Yuanquan, Wu, Xi, Deng, Ting, Ba, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569480/ https://www.ncbi.nlm.nih.gov/pubmed/34765950 http://dx.doi.org/10.1016/j.eclinm.2021.101157 |
Ejemplares similares
-
Neuroprotective effects of monosialotetrahexosylganglioside
por: Xi, Ai-ping, et al.
Publicado: (2015) -
Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer
por: Wang, De‐shen, et al.
Publicado: (2019) -
miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer
por: Ning, Tao, et al.
Publicado: (2022) -
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
por: Argyriou, Andreas A.
Publicado: (2015) -
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2021)